ID   S20A1_HUMAN             Reviewed;         679 AA.
AC   Q8WUM9; Q08344; Q6DHX8; Q9UQ82;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   15-MAR-2017, entry version 122.
DE   RecName: Full=Sodium-dependent phosphate transporter 1;
DE   AltName: Full=Gibbon ape leukemia virus receptor 1;
DE            Short=GLVR-1;
DE   AltName: Full=Leukemia virus receptor 1 homolog;
DE   AltName: Full=Phosphate transporter 1;
DE            Short=PiT-1;
DE   AltName: Full=Solute carrier family 20 member 1;
GN   Name=SLC20A1; Synonyms=GLVR1, PIT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=2078500;
RA   O'Hara B., Johann S.V., Klinger H.P., Blair D.G., Rubinson H.,
RA   Dunn K.J., Sass P., Vitek S.M., Robins T.;
RT   "Characterization of a human gene conferring sensitivity to infection
RT   by gibbon ape leukemia virus.";
RL   Cell Growth Differ. 1:119-127(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-646.
RX   PubMed=9889306; DOI=10.1016/S0378-1119(98)00572-1;
RA   Palmer G., Manen D., Bonjour J.-P., Caverzasio J.;
RT   "Characterization of the human Glvr-1 phosphate transporter/retrovirus
RT   receptor gene and promoter region.";
RL   Gene 226:25-33(1999).
RN   [5]
RP   FUNCTION.
RX   PubMed=1309898;
RA   Takeuchi Y., Vile R.G., Simpson G., O'Hara B., Collins M.K.,
RA   Weiss R.A.;
RT   "Feline leukemia virus subgroup B uses the same cell surface receptor
RT   as gibbon ape leukemia virus.";
RL   J. Virol. 66:1219-1222(1992).
RN   [6]
RP   FUNCTION, AND TOPOLOGY.
RX   PubMed=1531369;
RA   Johann S.V., Gibbons J.J., O'Hara B.;
RT   "GLVR1, a receptor for gibbon ape leukemia virus, is homologous to a
RT   phosphate permease of Neurospora crassa and is expressed at high
RT   levels in the brain and thymus.";
RL   J. Virol. 66:1635-1640(1992).
RN   [7]
RP   MUTAGENESIS OF 550-ASP--VAL-558 AND ASP-550, AND REGION.
RX   PubMed=8411375;
RA   Johann S.V., van Zeijl M., Cekleniak J., O'Hara B.;
RT   "Definition of a domain of GLVR1 which is necessary for infection by
RT   gibbon ape leukemia virus and which is highly polymorphic between
RT   species.";
RL   J. Virol. 67:6733-6736(1993).
RN   [8]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=7929240;
RA   Olah Z., Lehel C., Anderson W.B., Eiden M.V., Wilson C.A.;
RT   "The cellular receptor for gibbon ape leukemia virus is a novel high
RT   affinity sodium-dependent phosphate transporter.";
RL   J. Biol. Chem. 269:25426-25431(1994).
RN   [9]
RP   FUNCTION.
RX   PubMed=7966619;
RA   Miller D.G., Miller A.D.;
RT   "A family of retroviruses that utilize related phosphate transporters
RT   for cell entry.";
RL   J. Virol. 68:8270-8276(1994).
RN   [10]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND INDUCTION.
RX   PubMed=8041748; DOI=10.1073/pnas.91.15.7071;
RA   Kavanaugh M.P., Miller D.G., Zhang W., Law W., Kozak S.L., Kabat D.,
RA   Miller A.D.;
RT   "Cell-surface receptors for gibbon ape leukemia virus and amphotropic
RT   murine retrovirus are inducible sodium-dependent phosphate
RT   symporters.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:7071-7075(1994).
RN   [11]
RP   FUNCTION.
RX   PubMed=11009570; DOI=10.1161/01.RES.87.7.e10;
RA   Jono S., McKee M.D., Murry C.E., Shioi A., Nishizawa Y., Mori K.,
RA   Morii H., Giachelli C.M.;
RT   "Phosphate regulation of vascular smooth muscle cell calcification.";
RL   Circ. Res. 87:E10-E17(2000).
RN   [12]
RP   FUNCTION, MUTAGENESIS OF ASP-550, AND REGION.
RX   PubMed=12097582; DOI=10.1128/JVI.76.15.7683-7693.2002;
RA   Farrell K.B., Russ J.L., Murthy R.K., Eiden M.V.;
RT   "Reassessing the role of region A in Pit1-mediated viral entry.";
RL   J. Virol. 76:7683-7693(2002).
RN   [13]
RP   INDUCTION.
RX   PubMed=15641067; DOI=10.1002/art.20748;
RA   Cecil D.L., Rose D.M., Terkeltaub R., Liu-Bryan R.;
RT   "Role of interleukin-8 in PiT-1 expression and CXCR1-mediated
RT   inorganic phosphate uptake in chondrocytes.";
RL   Arthritis Rheum. 52:144-154(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-269, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-265 AND SER-269, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Sodium-phosphate symporter which plays a fundamental
CC       housekeeping role in phosphate transport, such as absorbing
CC       phosphate from interstitial fluid for normal cellular functions
CC       such as cellular metabolism, signal transduction, and nucleic acid
CC       and lipid synthesis. May play a role in extracellular matrix and
CC       cartilage calcification as well as in vascular calcification. May
CC       function as a retroviral receptor as it confers human cells
CC       susceptibility to infection to Gibbon Ape Leukemia Virus (GaLV),
CC       Simian sarcoma-associated virus (SSAV) and Feline leukemia virus
CC       subgroup B (FeLV-B) as well as 10A1 murine leukemia virus (10A1
CC       MLV). {ECO:0000269|PubMed:11009570, ECO:0000269|PubMed:12097582,
CC       ECO:0000269|PubMed:1309898, ECO:0000269|PubMed:1531369,
CC       ECO:0000269|PubMed:2078500, ECO:0000269|PubMed:7929240,
CC       ECO:0000269|PubMed:7966619, ECO:0000269|PubMed:8041748}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=24.1 uM for phosphate {ECO:0000269|PubMed:7929240,
CC         ECO:0000269|PubMed:8041748};
CC         Vmax=1.9 nmol/min/mg enzyme (in the presence of 0.05-2 mM
CC         phosphate) {ECO:0000269|PubMed:7929240,
CC         ECO:0000269|PubMed:8041748};
CC         Note=With an increase in pH, a decrease in phosphate uptake is
CC         observed.;
CC       pH dependence:
CC         Optimum pH is 6.5 and 7.5. {ECO:0000269|PubMed:7929240,
CC         ECO:0000269|PubMed:8041748};
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:2078500}.
CC   -!- INDUCTION: By phosphate deprivation as well as by IL8/interleukin-
CC       8 in hypertrophic chondrocytes. {ECO:0000269|PubMed:15641067,
CC       ECO:0000269|PubMed:8041748}.
CC   -!- DOMAIN: Region A confers human cells susceptibility to infection
CC       by Gibbon Ape Leukemia Virus (GaLV) and Feline leukemia virus
CC       subgroup B (FeLV-B). Substitution of Human SLC20A1 region A by
CC       region A of murine SLC20A1 prevents viral infection.
CC   -!- SIMILARITY: Belongs to the inorganic phosphate transporter (PiT)
CC       (TC 2.A.20) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L20859; AAA52572.1; -; mRNA.
DR   EMBL; AC079922; AAY14922.1; -; Genomic_DNA.
DR   EMBL; BC019944; AAH19944.1; -; mRNA.
DR   EMBL; BC075818; AAH75818.1; -; mRNA.
DR   EMBL; AH007490; AAD20286.1; -; Genomic_DNA.
DR   CCDS; CCDS2099.1; -.
DR   PIR; I52822; I52822.
DR   RefSeq; NP_005406.3; NM_005415.4.
DR   UniGene; Hs.187946; -.
DR   UniGene; Hs.732750; -.
DR   ProteinModelPortal; Q8WUM9; -.
DR   BioGrid; 112462; 25.
DR   IntAct; Q8WUM9; 6.
DR   STRING; 9606.ENSP00000272542; -.
DR   TCDB; 2.A.20.2.7; the inorganic phosphate transporter (pit) family.
DR   iPTMnet; Q8WUM9; -.
DR   PhosphoSitePlus; Q8WUM9; -.
DR   BioMuta; SLC20A1; -.
DR   DMDM; 74730735; -.
DR   EPD; Q8WUM9; -.
DR   MaxQB; Q8WUM9; -.
DR   PaxDb; Q8WUM9; -.
DR   PeptideAtlas; Q8WUM9; -.
DR   PRIDE; Q8WUM9; -.
DR   DNASU; 6574; -.
DR   Ensembl; ENST00000272542; ENSP00000272542; ENSG00000144136.
DR   GeneID; 6574; -.
DR   KEGG; hsa:6574; -.
DR   UCSC; uc002tib.4; human.
DR   CTD; 6574; -.
DR   DisGeNET; 6574; -.
DR   GeneCards; SLC20A1; -.
DR   HGNC; HGNC:10946; SLC20A1.
DR   HPA; CAB019279; -.
DR   HPA; HPA035834; -.
DR   MIM; 137570; gene.
DR   neXtProt; NX_Q8WUM9; -.
DR   OpenTargets; ENSG00000144136; -.
DR   PharmGKB; PA35833; -.
DR   eggNOG; KOG2493; Eukaryota.
DR   eggNOG; COG0306; LUCA.
DR   GeneTree; ENSGT00390000014879; -.
DR   HOGENOM; HOG000231892; -.
DR   HOVERGEN; HBG053358; -.
DR   InParanoid; Q8WUM9; -.
DR   KO; K14640; -.
DR   OMA; WINLATW; -.
DR   OrthoDB; EOG091G07J5; -.
DR   PhylomeDB; Q8WUM9; -.
DR   TreeFam; TF314426; -.
DR   BRENDA; 3.6.3.27; 2681.
DR   Reactome; R-HSA-427652; Sodium-coupled phosphate cotransporters.
DR   ChiTaRS; SLC20A1; human.
DR   GeneWiki; SLC20A1; -.
DR   GenomeRNAi; 6574; -.
DR   PRO; PR:Q8WUM9; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000144136; -.
DR   CleanEx; HS_SLC20A1; -.
DR   ExpressionAtlas; Q8WUM9; baseline and differential.
DR   Genevisible; Q8WUM9; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005316; F:high-affinity inorganic phosphate:sodium symporter activity; IEA:Ensembl.
DR   GO; GO:0005315; F:inorganic phosphate transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0004872; F:receptor activity; TAS:ProtInc.
DR   GO; GO:0004871; F:signal transducer activity; IMP:UniProtKB.
DR   GO; GO:0015321; F:sodium-dependent phosphate transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0005436; F:sodium:phosphate symporter activity; TAS:ProtInc.
DR   GO; GO:0006811; P:ion transport; TAS:Reactome.
DR   GO; GO:0006796; P:phosphate-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR001204; Phos_transporter.
DR   PANTHER; PTHR11101; PTHR11101; 1.
DR   Pfam; PF01384; PHO4; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Membrane; Phosphate transport; Phosphoprotein;
KW   Receptor; Reference proteome; Symport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    679       Sodium-dependent phosphate transporter 1.
FT                                /FTId=PRO_0000080771.
FT   TOPO_DOM      1     20       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     21     41       Helical. {ECO:0000255}.
FT   TOPO_DOM     42     61       Extracellular. {ECO:0000255}.
FT   TRANSMEM     62     82       Helical. {ECO:0000255}.
FT   TOPO_DOM     83     99       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    100    120       Helical. {ECO:0000255}.
FT   TOPO_DOM    121    157       Extracellular. {ECO:0000255}.
FT   TRANSMEM    158    178       Helical. {ECO:0000255}.
FT   TOPO_DOM    179    202       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    203    223       Helical. {ECO:0000255}.
FT   TOPO_DOM    224    229       Extracellular. {ECO:0000255}.
FT   TRANSMEM    230    250       Helical. {ECO:0000255}.
FT   TOPO_DOM    251    510       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    511    531       Helical. {ECO:0000255}.
FT   TOPO_DOM    532    557       Extracellular. {ECO:0000255}.
FT   TRANSMEM    558    578       Helical. {ECO:0000255}.
FT   TOPO_DOM    579    599       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    600    620       Helical. {ECO:0000255}.
FT   TOPO_DOM    621    649       Extracellular. {ECO:0000255}.
FT   TRANSMEM    650    670       Helical. {ECO:0000255}.
FT   TOPO_DOM    671    679       Cytoplasmic. {ECO:0000255}.
FT   REGION      550    558       A.
FT   MOD_RES     265    265       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     269    269       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MUTAGEN     550    558       DTGDVSSKV->KQEASTKA: Loss of virus
FT                                infectibility.
FT                                {ECO:0000269|PubMed:8411375}.
FT   MUTAGEN     550    550       D->K: Drastic reduction of virus
FT                                infectibility, but conserved virus
FT                                binding ability.
FT                                {ECO:0000269|PubMed:12097582,
FT                                ECO:0000269|PubMed:8411375}.
FT   MUTAGEN     550    550       Missing: Loss of virus infectibility.
FT                                {ECO:0000269|PubMed:12097582,
FT                                ECO:0000269|PubMed:8411375}.
FT   CONFLICT    376    376       Y -> S (in Ref. 1; AAA52572).
FT                                {ECO:0000305}.
FT   CONFLICT    443    443       E -> R (in Ref. 4; AAD20286).
FT                                {ECO:0000305}.
FT   CONFLICT    487    487       E -> A (in Ref. 1; AAA52572).
FT                                {ECO:0000305}.
SQ   SEQUENCE   679 AA;  73700 MW;  5545F6E6DC8F5EA8 CRC64;
     MATLITSTTA ATAASGPLVD YLWMLILGFI IAFVLAFSVG ANDVANSFGT AVGSGVVTLK
     QACILASIFE TVGSVLLGAK VSETIRKGLI DVEMYNSTQG LLMAGSVSAM FGSAVWQLVA
     SFLKLPISGT HCIVGATIGF SLVAKGQEGV KWSELIKIVM SWFVSPLLSG IMSGILFFLV
     RAFILHKADP VPNGLRALPV FYACTVGINL FSIMYTGAPL LGFDKLPLWG TILISVGCAV
     FCALIVWFFV CPRMKRKIER EIKCSPSESP LMEKKNSLKE DHEETKLSVG DIENKHPVSE
     VGPATVPLQA VVEERTVSFK LGDLEEAPER ERLPSVDLKE ETSIDSTVNG AVQLPNGNLV
     QFSQAVSNQI NSSGHYQYHT VHKDSGLYKE LLHKLHLAKV GDCMGDSGDK PLRRNNSYTS
     YTMAICGMPL DSFRAKEGEQ KGEEMEKLTW PNADSKKRIR MDSYTSYCNA VSDLHSASEI
     DMSVKAEMGL GDRKGSNGSL EEWYDQDKPE VSLLFQFLQI LTACFGSFAH GGNDVSNAIG
     PLVALYLVYD TGDVSSKVAT PIWLLLYGGV GICVGLWVWG RRVIQTMGKD LTPITPSSGF
     SIELASALTV VIASNIGLPI STTHCKVGSV VSVGWLRSKK AVDWRLFRNI FMAWFVTVPI
     SGVISAAIMA IFRYVILRM
//
